Browse studies, page 1238
Page 1238 of 1,286, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Levofloxacin for Patients with Ventilator Associated Pneumonia in ICU Zhongguo yiyuan ganranxue zazhi, 2007
- Observation of levofloxacin in the treatment of elderly diabetic patients with community-acquired pneumonia Journal of Clinical Pulmonary Medicine, 2008
- Comparison of Levofloxacin Alone and Cefuroxime Combined with Azithromycin for Patients with Community-acquired Pneumonia Zhongguo yiyuan ganranxue zazhi, 2007
- Clinical Evaluation of Levofloxacin Combined with Ceftriaxone Sodium in the Treatment of 30 Patients with Community-acquired Pneumonia Chinese Journal of Modern Drug Application, 2009
- Comparison of Levofloxacin Alone and Azithromycin Combined with Amoxicillin and Clavulanate Potassium for Patients with Community-acquired Pneumonia China Practical Medicine, 2010
- Potential Use of Selected Natural Compounds with Anti-Biofilm Activity International journal of molecular sciences, 2025
- Convalescent plasma therapy as a conventional trick for treating COVID-19: a systematic review and meta-analysis study New microbes and new infections, 2021
- Blood Stream Infections from MDR Bacteria Life (Basel, Switzerland), 2021
- Opportunities and Challenges for Inhalable Nanomedicine Formulations in Respiratory Diseases: A Review International journal of nanomedicine, 2024
- Cyclodextrin-Based Nanotransporters as a Versatile Tool to Manage Oxidative Stress-Induced Lung Diseases Antioxidants (Basel, Switzerland), 2025
- Invasive Infections Associated with the Use of Probiotics in Children: A Systematic Review Children (Basel, Switzerland), 2021
- Effectiveness of a Novel Liposomal Methylglyoxal-Tobramycin Formulation in Reducing Biofilm Formation and Bacterial Adhesion Antibiotics (Basel, Switzerland), 2024
- Prosthetic Joint Infection Research Models in NZW Rabbits: Opportunities for Standardization-A Systematic Review Journal of functional biomaterials, 2024
- Gram-Positive Pneumonia: Possibilities Offered by Phage Therapy Antibiotics (Basel, Switzerland), 2021
- Monitoring intracellular replication dynamics unveils high proportion of non-replicating antibiotic-tolerant Staphylococcus aureus inside osteoblasts PLoS pathogens, 2025
- Characterization of phage HZY2308 against Acinetobacter baumannii and identification of phage-resistant bacteria Virology journal, 2024
- Unlocking the potential of microalgae-derived therapeutic carriers: Characteristics, types, and nanomedical applications Materials today. Bio, 2025
- Characterizing the bacteriophage PKp-V1 as a potential treatment for ESBL-producing hypervirulent K1 Klebsiella pneumoniae ST258 isolated from veterinary specimens Veterinary world, 2024
- Enteric Fever: Diagnostic Challenges and the Importance of Early Intervention Cureus, 2023
- Unraveling topoisomerase IA gate dynamics in presence of PPEF and its preclinical evaluation against multidrug-resistant pathogens Communications biology, 2023
- Achyranthes aspera Extracts as Adjuvants for the Redressal of Antibiotic Resistance Pharmaceutics, 2022
- Recent Advances in Pharmaceutical Approaches of Antimicrobial Agents for Selective Delivery in Various Administration Routes Antibiotics (Basel, Switzerland), 2023
- Cyclodextrin: A prospective nanocarrier for the delivery of antibacterial agents against bacteria that are resistant to antibiotics Heliyon, 2023
- Bacteria-Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy Advanced materials (Deerfield Beach, Fla.), 2026
- Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023
- Actinobacillus ureae may be a critical pathogen in patients with predispositions: A case report and review of the literature Medicine, 2023
- A Dual Challenge: Coxiella burnetii Endocarditis in a Patient with Familial Thoracic Aortic Aneurysm-Case Report and Literature Review Journal of clinical medicine, 2024
- A Systematic Review of Controlled Trials: Can Patient Adherence to Antibiotics Be Improved Through Pharmaceutical Communication-Based Interventions? Pharmacy (Basel, Switzerland), 2024
- Zinc oxide resveratrol nanoparticles ameliorate testicular dysfunction due to levofloxacin-induced oxidative stress in rats Scientific reports, 2024
- Pharmacological evaluation of phage-antibiotic synergism against clinical isolates of multi-drug resistant Staphylococcus aureus in a burn-induced infection mouse model Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2025
- Multifunctional 3D-Printed Wound Dressings Containing a Combination of Synergistic Antimicrobials in the Management of MRSA Infected Topical Wounds ACS applied materials & interfaces, 2025
- Proteome mining of Yersinia Enterocolitica for drug targets and computational inhibitor identification with ADMET, anti-inflammation potential and formulation characteristics BioData mining, 2025
- Stenotrophomonas maltophilia Infection Associated with COVID-19: A Case Series and Literature Review The American journal of case reports, 2022
- Combating Klebsiella pneumoniae: from antimicrobial resistance mechanisms to phage-based combination therapies Frontiers in cellular and infection microbiology, 2025
- A systematic review of recent outbreaks and the efficacy and safety of drugs approved for the treatment of Salmonella infections IJID regions, 2025
- Therapeutic Management Strategies Among Immunocompetent Infants with Nontuberculous Mycobacterial Pulmonary Infection Pediatric health, medicine and therapeutics, 2025
- Natural Macrophage Membrane-Coated Nanoparticles as a Multifaceted Sepsis Therapeutic to Sequester Inflammatory and Toxic Mediators ACS nano, 2025
- Unveiling the potential of spirulina algal extract as promising antibacterial and antibiofilm agent against carbapenem-resistant Klebsiella pneumoniae: in vitro and in vivo study Microbial cell factories, 2025
- Combination Therapy versus Monotherapy in the Treatment of Stenotrophomonas maltophilia Infections: A Systematic Review and Meta-Analysis Antibiotics (Basel, Switzerland), 2022
- Pulmonary Delivery of Antibiotics to the Lungs: Current State and Future Prospects Pharmaceutics, 2025
- Pathobiology of ESKAPE Biofilms in implant infections: current understanding and implications for future therapeutic strategies Frontiers in cellular and infection microbiology, 2026
- Ventilator-Associated Pneumonia After Cardiac Arrest and Prevention Strategies: A Narrative Review Medicina (Kaunas, Lithuania), 2025
- Case Report: A case of spinal muscular atrophy with extensively drug-resistant Acinetobacter baumannii pneumonia treated with nebulization combined with intravenous polymyxin B: experience and a literature review Frontiers in cellular and infection microbiology, 2023
- Isolation and characterization of ɸEcM-vB1 bacteriophage targeting multidrug-resistant Escherichia coli BMC research notes, 2025
- In vitro, genomic characterization and pre-clinical evaluation of a new thermostable lytic Obolenskvirus phage formulated as a hydrogel against carbapenem-resistant Acinetobacter baumannii Scientific reports, 2025
- Rare or Unusual Non-Fermenting Gram-Negative Bacteria: Therapeutic Approach and Antibiotic Treatment Options Antibiotics (Basel, Switzerland), 2025
- Re-Emergence of Bacteriophages and Their Products as Antibacterial Agents: An Overview International journal of molecular sciences, 2025
- Precision nanomedicine for pulmonary diseases: from molecular targeting to clinical translation Signal transduction and targeted therapy, 2026
- Prophylactic and therapeutic efficacy of Acinetobacter phage RM_A1 against carbapenem-resistant Acinetobacter baumannii with no cytotoxicity to human skin cells BMC microbiology, 2026
- Clinical implementation of endolysins targeting gram-positive bacteria points toward a combination strategy with standard-of-care antibiotics: a selective review European journal of medical research, 2026
- Antimicrobial Peptides in Preventive Medicine: Current Perspectives on Coating Strategies ACS infectious diseases, 2026
- Pulmonary Drug Delivery for Infectious Diseases: Cutting-Edge Formulations and Manufacturing Technologies Pharmaceutics, 2026
- Advances in Inhaled Nanoparticle Drug Delivery for Pulmonary Disease Management FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2025
- Nanomedicines for Pulmonary Drug Delivery: Overcoming Barriers in the Treatment of Respiratory Infections and Lung Cancer Pharmaceutics, 2024
- Development of Membrane-Targeting Cannabigerol Derivatives as Potent Broad-Spectrum Antibacterial Agents Drug design, development and therapy, 2026
- Protecting Newborns from Multidrug-Resistant Infections: The Emerging Role of Bacteriophages Viruses, 2026
- In vivo efficacy of human simulated regimens of carbapenems and comparator agents against NDM-1-producing Enterobacteriaceae Antimicrobial agents and chemotherapy, 2014
- In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem Antimicrobial agents and chemotherapy, 2005
- In vitro and in vivo antibacterial activity of modithromycin against streptococci and Haemophilus influenzae The Journal of antimicrobial chemotherapy, 2011
- Performance in practice: bacteriological efficacy in patients with drug-resistant S. pneumoniae Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004
- Prediction of antimicrobial resistance in Klebsiella pneumoniae using genomic and metagenomic next-generation sequencing data The Journal of antimicrobial chemotherapy, 2024
- In vitro and in vivo antibacterial activities of DC-159a, a new fluoroquinolone Antimicrobial agents and chemotherapy, 2008
- Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins Clinical Microbiology and Infection, 2021
- Empiric antibiotic therapy for moderate-to-severe community-acquired pneumonia: a systematic review and network meta-analysis Clinical Microbiology and Infection, 2025
- The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions Chemical Society Reviews, 2021
- Systematic Review of Antimicrobial Combination Options for Pandrug-Resistant Acinetobacter baumannii Antibiotics, 2021
- Systematic review and meta-analysis of the efficacy and safety of oseltamivir (Tamiflu) in the treatment of Coronavirus Disease 2019 (COVID-19) PLoS ONE, 2022
- Comparative Efficacy and Safety of Potassium-Competitive Acid Blockers vs. Proton Pump Inhibitors for Peptic Ulcer with or without Helicobacter pylori Infection: A Systematic Review and Network Meta-Analysis Pharmaceuticals, 2024
- Duration of Antimicrobial Treatment in Adult Patients with Pneumonia: A Narrative Review Antibiotics, 2024
- Comparative Efficacy of Oral Chinese Patent Medicine for Chronic Prostatitis/Chronic Pelvic Pain Syndrome With Sexual Dysfunction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials Frontiers in Pharmacology, 2021
- Efficacy and safety of tigecycline for complicated urinary tract infection: a systematic review Translational Andrology and Urology, 2021
- Community-acquired pneumonia: similarities and differences between European and American guidelines – A narrative review – Revista Española de Quimioterapia, 2020
- Colistin Nephrotoxicity: Meta-Analysis of Randomized Controlled Trials Open Forum Infectious Diseases, 2021
- The Efficacy and Safety of Doripenem in the Treatment of Acute Bacterial Infections—A Systemic Review and Meta-Analysis of Randomized Controlled Trials Journal of Clinical Medicine, 2019
- Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review Antimicrobial Resistance and Infection Control, 2019
- Efficacy and Safety of Hydroxychloroquine for Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis Journal of Clinical Medicine, 2021
- Guideline-Concordant Therapy for Community-Acquired Pneumonia in the Hospitalized Population: A Systematic Review and Meta-analysis Open Forum Infectious Diseases, 2024
- Nanoparticles in Antibacterial Therapy: A Systematic Review of Enhanced Efficacy against Intracellular Bacteria ACS Omega, 2025
- Macrolides for better resolution of community-acquired pneumonia: A global meta-analysis of clinical outcomes with focus on microbial aetiology International Journal of Antimicrobial Agents, 2023
- Could Xuebijing Injection Reduce the Mortality of Severe Pneumonia Patients? A Systematic Review and Meta‐Analysis Evidence-based Complementary and Alternative Medicine, 2020
- Efficacy and Safety of Sitafloxacin in the Treatment of Acute Bacterial Infection: A Meta-analysis of Randomized Controlled Trials Antibiotics, 2020
- A quality assessment of evidence-based guidelines for the prevention and management of ventilator-associated pneumonia: a systematic review Journal of Thoracic Disease, 2019
- Chinese Patent Medicine Shufeng Jiedu Capsules as an Adjuvant Therapy for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials Frontiers in Pharmacology, 2022
- Efficacy of Chinese Herbal Injections for Elderly Patients With pneumonia—A Bayesian Network Meta-analysis of Randomized Control Trials Frontiers in Pharmacology, 2021
- Five-day antibiotic treatment for community-acquired bacterial pneumonia: A systematic review and meta-analysis of randomized controlled trials Journal of Global Antimicrobial Resistance, 2020
- Advancements in the Management of Severe Community-Acquired Pneumonia: A Comprehensive Narrative Review Cureus, 2023
- Aetiological agents of adult community-acquired pneumonia in Japan: systematic review and meta-analysis of published data BMJ Open Respiratory Research, 2023
- Estimating the burden of antimicrobial resistance: a systematic literature review Antimicrobial Resistance and Infection Control, 2018
- Stenotrophomonas maltophilia Infections: A Systematic Review and Meta-Analysis of Comparative Efficacy of Available Treatments, with Critical Assessment of Novel Therapeutic Options Antibiotics, 2023
- Ventilator-associated pneumonia in critically ill patients with COVID-19 infection: a narrative review ERJ Open Research, 2022
- Atypical Pathogens in Adult Community-Acquired Pneumonia and Implications for Empiric Antibiotic Treatment: A Narrative Review Microorganisms, 2022
- Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trials Critical Care, 2017
- Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review Journal of Clinical Medicine, 2020
- Ventilator-Associated Pneumonia Prevention in Pediatric Patients: Narrative Review Children, 2022
- Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis European Respiratory Journal, 2008
- Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research Nature Reviews Microbiology, 2019
- Systematic review on antibiotic therapy for pneumonia in children between 2 and 59 months of age Archives of Disease in Childhood, 2014
- Cardiovascular Events after Community-Acquired Pneumonia: A Global Perspective with Systematic Review and Meta-Analysis of Observational Studies Journal of Clinical Medicine, 2020
- Corticosteroid Therapy for Severe Community-Acquired Pneumonia: A Meta-Analysis Respiratory Care, 2013
- Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review BMC Pulmonary Medicine, 2010
